We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$118M
2
DLR icon
Digital Realty Trust
DLR
+$106M
3
CCI icon
Crown Castle
CCI
+$104M
4
SPG icon
Simon Property Group
SPG
+$93M
5
KIM icon
Kimco Realty
KIM
+$64.5M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNLI icon
1101
Denali Therapeutics
DNLI
$3.82B
$10K ﹤0.01%
475
-71
-13% -$1.82K
IEF icon
1102
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$10K ﹤0.01%
113
-71
-39% -$6.71K
JANX icon
1103
Janux Therapeutics
JANX
$915M
$10K ﹤0.01%
187
– –
KYMR icon
1104
Kymera Therapeutics
KYMR
$8.73B
$10K ﹤0.01%
245
– –
TWST icon
1105
Twist Bioscience
TWST
$5.51B
$10K ﹤0.01%
210
– –
XENE icon
1106
Xenon Pharmaceuticals
XENE
$6.28B
$10K ﹤0.01%
252
-36
-13% -$1.49K
DYN icon
1107
Dyne Therapeutics
DYN
$4.28B
$9K ﹤0.01%
371
– –
EWTX icon
1108
Edgewise Therapeutics
EWTX
$4.34B
$9K ﹤0.01%
344
– –
FOLD
1109
DELISTED
Amicus Therapeutics
FOLD
$9K ﹤0.01%
986
-144
-13% -$1.5K
SWTX
1110
DELISTED
SpringWorks Therapeutics
SWTX
$9K ﹤0.01%
245
-46
-16% -$1.61K
VCEL icon
1111
Vericel Corp
VCEL
$2.39B
$9K ﹤0.01%
163
-27
-14% -$1.37K
AMRX icon
1112
Amneal Pharmaceuticals
AMRX
$5.99B
$8K ﹤0.01%
+1,023
New +$8.58K
APGE icon
1113
Apogee Therapeutics
APGE
$10.1B
$8K ﹤0.01%
171
– –
ARWR icon
1114
Arrowhead Research
ARWR
$12.1B
$8K ﹤0.01%
426
– –
GERN icon
1115
Geron
GERN
$930M
$8K ﹤0.01%
2,247
– –
MIRM icon
1116
Mirum Pharmaceuticals
MIRM
$6.84B
$8K ﹤0.01%
188
– –
NAMS icon
1117
NewAmsterdam Pharma
NAMS
$3.27B
$8K ﹤0.01%
+305
New +$6.48K
PTGX icon
1118
Protagonist Therapeutics
PTGX
$8.8B
$8K ﹤0.01%
215
– –
SUPN icon
1119
Supernus Pharmaceuticals
SUPN
$2.77B
$8K ﹤0.01%
209
– –
VERA icon
1120
Vera Therapeutics
VERA
$2.39B
$8K ﹤0.01%
182
– –
XLK icon
1121
State Street Technology Select Sector SPDR ETF
XLK
$112B
$8K ﹤0.01%
70
-72
-51% -$8.38K
AGIO icon
1122
Agios Pharmaceuticals
AGIO
$2.14B
$7K ﹤0.01%
204
– –
AKRO
1123
DELISTED
Akero Therapeutics
AKRO
$7K ﹤0.01%
262
– –
AMPH icon
1124
Amphastar Pharmaceuticals
AMPH
$888M
$7K ﹤0.01%
185
– –
BCE icon
1125
BCE
BCE
$20.3B
$7K ﹤0.01%
300
-150
-33% -$4.31K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.